With this study, we add a new dimension to the GATA3mut landscape by analyzing ctDNA in MBC and demonstrate that GATA3 mutations are detectable, as well as co-occurring potential modifiers, and cancers harboring these mutations have distinct ctDNA-based genomic characteristics compared to those identified in primary breast cancer tissue. The gene discussed is GATA3; the disease is breast cancer.